Notably, the levels of HMW GFAPs in AxD patients correlated with the detection of increased accumulation of GFAP degradation products, one of which was likely to be caspase 6-generated (Fig. 1C, p26 indicated by an arrow) (51). This evidence concerns the gene CASP6 and Alexander disease.